Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
γδ T lymphocytes are potent effector cells, capable of efficiently killing tumor and leukemia cells. Their activation is mediated by γδ T-cell receptor (TCR) and by activating receptors shared with NK cells (e.g., NKG2D and DNAM-1). γδ T-cell triggering occurs upon interaction with specific ligands,...
Main Authors: | Vito Pistoia, Nicola Tumino, Paola Vacca, Irene Veneziani, Alessandro Moretta, Franco Locatelli, Lorenzo Moretta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00984/full |
Similar Items
-
Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report
by: Elmira I. Kolgaeva, et al.
Published: (2021-07-01) -
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia
by: Pietro Merli, et al.
Published: (2020-05-01) -
γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
by: Kok Fei Chan, et al.
Published: (2022-07-01) -
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
by: Emelie Rådestad, et al.
Published: (2019-02-01) -
Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease
by: Haitham Abdelhakim, et al.
Published: (2017-06-01)